Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Dev Weerasuriya's Stock Ratings
Berenberg Analyst
Dev Weerasuriya is an analyst at Berenberg. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/03/2025
Overall Average Return
-21.5%
Smart Score
Overall Average Return Percentile
12th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/29/2022 | NARI | Buy Now | Inari Medical | — | — | Dev Weerasuriya12% | → $85 | Initiates | → Buy | Get Alert |
| 07/29/2022 | DOCS | Buy Now | Doximity | $59.34 | -17.43% | Dev Weerasuriya12% | → $49 | Initiates | → Buy | Get Alert |
| 07/28/2022 | DOCS | Buy Now | Doximity | $59.34 | -17.43% | Dev Weerasuriya12% | → $49 | Initiates | → Buy | Get Alert |
| 04/28/2022 | BBLN | Buy Now | Babylon Holdings | — | — | Dev Weerasuriya12% | → $137.5 | Initiates | → Hold | Get Alert |
| 09/30/2021 | PGNY | Buy Now | Progyny | $23.23 | 248.69% | Dev Weerasuriya12% | → $81 | Initiates | → Buy | Get Alert |
| 09/30/2021 | ACCD | Buy Now | Accolade | — | — | Dev Weerasuriya12% | → $61 | Initiates | → Buy | Get Alert |
